Coverage
-
June 24, 2016
A Massachusetts federal judge has dismissed a shareholder suit alleging Biogen Inc. misled investors, finding the shareholders couldn't prove Biogen executives intentionally played down the impact of a safety issue with its main drug in rosy growth forecasts.
2 other articles on this case.
View all »